Reverberi Gian Piero

CIK 00016520231 companyWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0001652023

Recent Transactions

24 trades

Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-03-02$10.18/sh−1,450→ 165,384 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-01-02$16.06/sh−1,155→ 166,834 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-03-04$19.92/sh−443→ 167,989 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-03-01$20.16/sh−438→ 168,432 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2019-02-27+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-02-27+30,000→ 168,870 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-02$26.28/sh−600→ 139,400 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-02$26.93/sh−530→ 138,870 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-02-28+30,000→ 140,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2018-02-28+70,000→ 70,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2018-01-02−12,500→ 25,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-01-02+12,500→ 87,500 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-01-02+7,500→ 110,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2018-01-02−7,500→ 15,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2017-03-01+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2017-03-01+30,000→ 50,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2017-01-03+12,500→ 12,500 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2017-01-03+7,500→ 20,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2017-01-03+7,500→ 22,500 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2017-01-03+12,500→ 37,500 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2016-02-12+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2016-02-12+30,000→ 30,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2015-09-08+150,000→ 150,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Restricted Stock Unit
2015-09-08+50,000→ 50,000 total

Companies

Vanda Pharmaceuticals Inc.
SVP, General Manager Europe
$VNDA

Recent Filings

Address

2200 PENNSYLVANIA AVENUE SUITE 300E

WASHINGTON, DC, 20037

View on SEC.gov